Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 13.81 | 11.05 |
PEG Ratio (TTM) | -0.30 | -0.44 |
P/S Ratio (TTM) | 0.78 | 2.83 |
P/B Ratio (TTM) | 4.49 | 2.91 |
P/FCF Ratio (TTM) | 42.18 | 13.21 |
Price to 5YR AVG Earnings Ratio | N/A | 9.59 |
Price to 5YR AVG FCF Ratio | N/A | 9.11 |
Profitability (55%) |
Company | Industry |
---|---|---|
ROA (TTM) | 12.85% | 1.93% |
ROE (TTM) | 36.16% | 11.79% |
Net Profit Margin (TTM) | 5.61% | -123.61% |
ROIC 5YR AVG | N/A | 22.40% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -54.62% | N/A | N/A |
Revenue | -0.45% | N/A | N/A |
Net Income | -54.69% | N/A | N/A |
Cash Flow | -158.94% | N/A | N/A |
Health (58%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.72 | 1.81 |
Quick Ratio (TTM) | 0.54 | 0.87 |
D/E Ratio (TTM) | 0.28 | 1.64 |
Interest Coverage (TTM) | 42.81 | 14.50 |
Piotroski F-Score | 8 | 7 |
Altman Z-Score | 5.42 | 2.74 |
LTL to 5YR AVG FCF | N/A | 5.05 |
Shares Outstanding Growth 5YR AVG | N/A | -1.99% |